Collective Fear, Individualized Risk: the social and cultural context of genetic testing forbreast cancer

The purpose of this article is to provide a critical examination of two aspects of culture and biomedicine that have helped to shape the meaning and practice of genetic testing for breast cancer. These are: (1) the cultural construction of fear of breast cancer, which has been fuelled in part by (2) the predominance of a ‘risk’ paradigm in contemporary biomedicine. The increasing elaboration and delineation of risk factors and risk numbers are in part intended to help women to contend with their fear of breast cancer. However, because there is no known cure or foolproof prevention for breast cancer, risk designations bring with them recommendations for vigilant surveillance strategies and screening guidelines. We argue that these in effect exacerbate women’s fears of breast cancer itself. The volatile combination of discourses of fear, risk and surveillance have significant ethical and social consequences for women’s lives and well-being. Genetic testing decisions are made within this context; if nurses understand this context they can play an important role in helping women to cope with the anxiety and fear of breast cancer risk.

[1]  Alan Petersen,et al.  Foucault, Health and Medicine , 2002 .

[2]  L. Pinsky,et al.  BRCA1 and BRCA2: a small part of the puzzle. , 1999, Journal of the National Cancer Institute.

[3]  B. Lerner,et al.  Great expectations: historical perspectives on genetic breast cancer testing. , 1999, American journal of public health.

[4]  B. Rimer,et al.  The impact of a brief coping skills intervention on adherence to breast self‐examination among first‐degree relatives of newly diagnosed breast cancer patients , 1999, Psycho-oncology.

[5]  N. Holtzman,et al.  Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer , 1999, The Lancet.

[6]  R. Mansel,et al.  Anxiety and adherence to breast self-examination in women with a family history of breast cancer. , 1999, Psychosomatic medicine.

[7]  T. Raffin,et al.  Genetic testing for BRCA1 and BRCA2: recommendations of the Stanford Program in Genomics, Ethics, and Society. Breast Cancer Working Group. , 1998, Journal of women's health.

[8]  A. Howson.  Surveillance, knowledge and risk: the embodied experience of cervical screening , 1998 .

[9]  D. Macdonald.  Genetic predisposition testing for cancer: effects on families' lives. , 1998, Holistic nursing practice.

[10]  R. Croyle,et al.  The new genetics: Psychological responses to genetic testing , 1998 .

[11]  F. Speizer,et al.  Alcohol and breast cancer in women: a pooled analysis of cohort studies. , 1998, JAMA.

[12]  P. Devilee,et al.  BRCA1 in the family: a case description of the psychological implications. , 1997, American journal of medical genetics.

[13]  G. Goon,et al.  Breast cancer detection by daughters of women with breast cancer. , 1997, Cancer practice.

[14]  K. Calzone.  Genetic predisposition testing: clinical implications for oncology nurses. , 1997, Oncology nursing forum.

[15]  T. Watson.  The politics of breast cancer. , 1997, U.S. news & world report.

[16]  P. Borgen,et al.  Genetic susceptibility for breast cancer: testing and primary prevention options. , 1997, Oncology nursing forum.

[17]  J. Mulvihill,et al.  Breast cancer risk analysis and counseling. , 1996, Clinical obstetrics and gynecology.

[18]  L. Parker,et al.  Standards of care and ethical concerns in genetic testing and screening. , 1996, Clinical obstetrics and gynecology.

[19]  D. Abeliovich,et al.  [Inherited breast cancer]. , 1996, Harefuah.

[20]  D. Trichopoulos,et al.  Determinants of age at menarche as early life predictors of breast cancer risk , 1996, International journal of cancer.

[21]  D. Easton,et al.  Psychosocial impact of testing (by linkage) for the BRCA1 breast cancer gene: An investigation of two families in the research setting , 1996 .

[22]  Barbara L. Smith,et al.  Perception of breast cancer risk among women in breast center and primary care settings: correlation with age and family history of breast cancer. , 1996, Surgery.

[23]  B. Trock,et al.  BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. , 1996, JAMA.

[24]  B. Hulka,et al.  Breast cancer: cause and prevention , 1995, The Lancet.

[25]  K. Kash.  Psychosocial and Ethical Implications of Defining Genetic Risk for Cancers a , 1995, Annals of the New York Academy of Sciences.

[26]  L. Parker.  Breast cancer genetic screening and critical bioethics' gaze. , 1995, The Journal of medicine and philosophy.

[27]  D. Armstrong,et al.  The rise of surveillance medicine , 1995 .

[28]  R F Nease,et al.  Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. , 1995, Journal of the National Cancer Institute.

[29]  S. Mahon.  Prevention and early detection of cancer in women. , 1995, Seminars in oncology nursing.

[30]  Jana Sawicki.  Disciplining Foucault: Feminism, Power, and the Body , 1994 .

[31]  N Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994, Cancer.

[32]  D. Lupton.  Risk as Moral Danger: The Social and Political Functions of Risk Discourse in Public Health , 1993, International journal of health services : planning, administration, evaluation.

[33]  M. King,et al.  Inherited breast and ovarian cancer. What are the risks? What are the choices? , 1993, JAMA.

[34]  M. Henderson.  Current approaches to breast cancer prevention , 1993, Science.

[35]  E Marshall,et al.  Epidemiology. Search for a killer: focus shifts from fat to hormones , 1993, Science.

[36]  P. E. Smith,et al.  Familial breast and ovarian cancers. , 1992, Seminars in oncology nursing.

[37]  P. Guttorp,et al.  The Taming of Chance. , 1992 .

[38]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[39]  J. Cockburn.  For her own good. 150 years of the experts' advice to women , 1979, Medical History.

[40]  S. Reiser.  The birth of the clinic: An archeology of medical perception: by Michel Foucault, translated by A.M. Sheridan Smith. Pantheon Press, New York and London, 1973. 215 pp. £4.20. , 1976 .

[41]  M. Douglas,et al.  Purity and Danger: An Analysis of Concepts of Pollution and Taboo. , 1967 .

[42]  B. Stoll.  Perimenopausal weight gain and progression of breast cancer precursors. , 1999, Cancer detection and prevention.

[43]  W. Burke,et al.  How are Jewish women different from all other women? Anthropological perspectives on genetic susceptibility testing for breast cancer. , 1997, Health matrix.

[44]  J. E. Nash,et al.  Psychological responses to BRCA1 mutation testing: preliminary findings. , 1997, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[45]  J Benichou,et al.  Graphs to estimate an individualized risk of breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  E. Parens.  Glad and terrified: on the ethics of BRACA1 and 2 testing. , 1996, Cancer investigation.

[47]  C Engelking,et al.  New approaches: innovations in cancer prevention, diagnosis, treatment, and support. , 1994, Oncology nursing forum.

[48]  M. Stefanek,et al.  Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. , 1994, Journal of the National Cancer Institute. Monographs.

[49]  B. Turner,et al.  Medical power and social knowledge , 1987 .

[50]  C. Fox,et al.  Breast-cancer screening. , 1979, Lancet.